- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05261607
Analysis of the Evolution of Mortality in an Intensive Care Unit
Epidemiological Analysis of the Evolution of the Case-mix and Mortality in the Intensive Care Unit of Hospital Universitario De Getafe (1991-2026)
The intensive care units is of the main components of modern healthcare systems. Formally, its aim is to offer the critically ill health care fit to their needs; ensuring that this health care is appropriate, sustainable, ethical and respectful of their autonomy. Intensive medicine is a cross-sectional specialty that encompasses a broad spectrum of pathologies in their most severe condition, and specifically has as its foundation the practice of comprehensive care of the patient with organ dysfunction and susceptible to recovery. Although critically ill patients are a heterogeneous population, they have in common the need for a high level of care, often requiring the use of high technology, specific procedures for the support of organ dysfunction and the collaboration of other medical and surgical specialties for their management and treatment.
Since their origins in the late 1950s, intensive care units have been adapting to the changes arising from the best scientific evidence. In the late 1990s and early 2000s, there were some successful clinical trials published that had tested alternative management strategies in the ICU.
Mechanical ventilation is an intervention that defines the critical care specialty. Between 1970 and the 1990s, the management focused on normalizing arterial blood gas with aggressive mechanical ventilation. Over the ensuing decades, it became apparent that performing positive pressure ventilation worsened lung injury. The pivotal moment in the mechanical ventilation story would be the low versus high tidal volume trial. This trial shifted the focus away from normalizing gas exchange to reducing harm with mechanical ventilation. Further, it paved way for further trials testing ventilation interventions (PEEP strategy, prone position ventilation) and nonventilation interventions (neuromuscular blockade, corticosteroids, inhaled nitric oxide, extracorporeal gas exchange) in critically ill patients.
That evidence-based intensive care medicine has undoubtedly had an influence on the outcome of critically ill patients, in general, and, particularly, of patients requiring mechanical ventilation. Temporal changes in mortality over the time have been scarcely reported for patients admitted to intensive care unit.
Objective of this study is to estimate the changes over the time in several outcomes in the patients admitted to an 18-beds medical-surgical intensive care unit from 1991 (year of start of activity) to 2026
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Fernando Frutos-Vivar, MD
- Phone Number: 462766 34916839360
- Email: fernando.frutos@salud.madrid.org
Study Locations
-
-
Madrid
-
Getafe, Madrid, Spain, 28905
- Recruiting
- Hospital Universitario de Getafe
-
Contact:
- Fernando Frutos-Vivar, MD
- Phone Number: 462766 +34916839360
- Email: fernando.frutos@salud.madrid.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
• Patients admitted to intensive care unit
Exclusion Criteria:
• None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intensive Care Unit Mortality
Time Frame: 180 days
|
Died during stay in the intensive care unit
|
180 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Mortality
Time Frame: 180 days
|
Died during stay in the hospital
|
180 days
|
|
Mortality 28-day
Time Frame: 28 days from date of admission in the Hospital
|
Mortality at day 28 after admission in the Hospital
|
28 days from date of admission in the Hospital
|
|
Use of Mechanical ventilation
Time Frame: 180 days
|
Proportion of patients who required mechanical ventilation (invasive and non-invasive) during stay in the intensive care unit
|
180 days
|
|
Length of stay in the intensive care unit
Time Frame: 180 days
|
Stay in the intensive care unit
|
180 days
|
|
Length of stay in the hospital
Time Frame: 180 days
|
Stay in the hospital
|
180 days
|
|
Complications/events during stay in the intensive care unit
Time Frame: 180 days
|
Rate of complications/events occurred in the intensive care unit
|
180 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fernando Frutos-Vivar, MD, Hospital Universitario de Getafe
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Evolution mortality ICU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.